Abstract
Background and purpose
Tolosa-Hunt Syndrome (THS) is a rare disorder, and detailed clinical information and treatment outcomes have yet to be fully elucidated. This study aims to investigate the clinical features and factors associated with the treatment outcomes of THS, as defined by the established diagnostic criteria.
Methods
This study retrospectively recruited 91 patients with a diagnosis of THS from 2003 to 2020. We analyzed the clinical features and outcomes, the initial treatment response, recurrences, and the final treatment response.
Results
Isolated ocular motor nerve palsy was the most common (82.4%) finding of ophthalmoplegia, involving the oculomotor nerve in more than half of the cases (52.0%). The MRI lesions were mostly observed in the cavernous sinus (94.5%) with an extracavernous extension in about one-third of them. Five patients showed only extracavernous lesions. A total of 25 (27.5%) patients experienced recurrence. Recurrence occurred during steroid tapering as part of the initial treatment in seven, while in 18 patients, it happened after the successful termination of the initial treatment. However, all patients achieved complete remission at the final. Age was associated with a decrease in initial symptom duration (HR = 1.023, CI = 1.004–1.044) as well as an increase in recurrence-free duration (HR = 0.944, CI = 0.911–0.978). High-dose corticosteroid treatment was associated with a decrease in initial symptom duration (HR = 1.642, CI = 1.001–2.695) and total treatment duration (HR = 2.203 CI = 1.302–3.730).
Conclusions
THS can recur frequently especially in younger but have a favorable prognosis. High-dose corticosteroids can be an effective initial treatment and reduce the total treatment duration.
Similar content being viewed by others
Data availability statement
Anonymized data will be shared by request from any qualified investigator.
References
Gladstone JP (2007) An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa-Hunt syndrome. Curr Pain Headache Rep 11(4):317–325. https://doi.org/10.1007/s11916-007-0211-7
Kline LB, Hoyt WF (2001) The Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry 71(5):577–582. https://doi.org/10.1136/jnnp.71.5.577
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38(1):1–211. doi:https://doi.org/10.1177/0333102417738202
Iaconetta G, Stella L, Esposito M, Cappabianca P (2005) Tolosa-Hunt syndrome extending in the cerebello-pontine angle. Cephalalgia 25(9):746–750. https://doi.org/10.1111/j.1468-2982.2005.00924.x
La Mantia L, Curone M, Rapoport AM, Bussone G, International Headache Society (2006) Tolosa-Hunt syndrome: critical literature review based on IHS 2004 criteria. Cephalalgia 26(7):772–781. https://doi.org/10.1111/j.1468-2982.2006.01115.x
Colnaghi S, Versino M, Marchioni E et al (2008) ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus. Cephalalgia 28(6):577–584. https://doi.org/10.1111/j.1468-2982.2008.01569.x
Zhang X, Zhang W, Liu R, Dong Z, Yu S (2014) Factors that influence Tolosa-Hunt syndrome and the short-term response to steroid pulse treatment. J Neurol Sci 341(1–2):13–16. https://doi.org/10.1016/j.jns.2014.03.031
Zhang X, Zhou Z, Steiner TJ et al (2014) Validation of ICHD-3 beta diagnostic criteria for 13.7 Tolosa-Hunt syndrome: Analysis of 77 cases of painful ophthalmoplegia. Cephalalgia 34(8):624–632. https://doi.org/10.1177/0333102413520082
Hao R, He Y, Zhang H, Zhang W, Li X, Ke Y (2015) The evaluation of ICHD-3 beta diagnostic criteria for Tolosa-Hunt syndrome: a study of 22 cases of Tolosa-Hunt syndrome. Neurol Sci 36(6):899–905. https://doi.org/10.1007/s10072-015-2124-2
Arthur A, Sivadasan A, Mannam P et al (2020) Tolosa-Hunt syndrome: long-term outcome and role of steroid-sparing agents. Ann Indian Acad Neurol 23(2):201–205. https://doi.org/10.4103/aian.AIAN_368_18
Kim H, Oh SY (2021) The clinical features and outcomes of Tolosa-Hunt syndrome. BMC Ophthalmol 21(1):237. https://doi.org/10.1186/s12886-021-02007-0. (Published 2021 May 27)
Ata F, Yousaf Z, Arachchige SNM et al (2021) The demographics of Tolosa-Hunt syndrome in Qatar. NeurologicalSci 24:100359. https://doi.org/10.1016/j.ensci.2021.100359. (Published 2021 Jul 22)
Sánchez Vallejo R, Lopez-Rueda A, Olarte AM, San RL (2014) MRI findings in Tolosa-Hunt syndrome (THS). BMJ Case Rep. https://doi.org/10.1136/bcr-2014-206629. (Published 2014 Nov 3)
Yang Y, Lai C, Yan F, Wang J (2020) Clinical significance of MRI contrast enhancement of the oculomotor nerve in ischemic isolated oculomotor nerve palsy. J Clin Neurol 16(4):653–658. https://doi.org/10.3988/jcn.2020.16.4.653
Hung CH, Chang KH, Wu YM et al (2013) A comparison of benign and inflammatory manifestations of Tolosa-Hunt syndrome. Cephalalgia 33(10):842–852. https://doi.org/10.1177/0333102412475238
Yeşiltaş YS, Gündüz AK (2018) Idiopathic orbital inflammation: review of literature and new advances. Middle East Afr J Ophthalmol 25(2):71–80. https://doi.org/10.4103/meajo.MEAJO_44_18
Vailati A, Marena C, Comis S et al (1993) Hashimoto’s thyroiditis in association with Tolosa Hunt syndrome: a case report. Thyroid 3(2):125–127. https://doi.org/10.1089/thy.1993.3.125
Piamonte BLC, Ong KL, Cenina AR (2021) Tolosa-Hunt syndrome relapse during pregnancy following chronic intake of combined oral contraceptives. BMJ Case Rep 14(1):e238944. https://doi.org/10.1136/bcr-2020-238944. (Published 2021 Jan 18)
Chen J, Ye H, Xiao W et al (2021) Increased dysfunctional and plastic regulatory T Cells in idiopathic orbital inflammation. Front Immunol 12:634847. https://doi.org/10.3389/fimmu.2021.634847
Moon SJ, Park HS, Kwok SK et al (2013) Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy. Lupus 22(5):527–537. https://doi.org/10.1177/0961203313476357
Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R (1999) Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index Lupus 8(6):462–465. https://doi.org/10.1177/096120339900800609
Vadasz Z, Haj T, Kessel A, Toubi E (2013) Age-related autoimmunity. BMC Med 11:94. https://doi.org/10.1186/1741-7015-11-94. (Published 2013 Apr 4)
Dutta P, Anand K (2021) Tolosa-Hunt syndrome: a review of diagnostic criteria and unresolved issues. J Curr Ophthalmol 33(2):104–111. https://doi.org/10.4103/joco.joco_134_20. (Published 2021 Jul 5)
Funding
This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2020R1A2C4002281).
Author information
Authors and Affiliations
Contributions
HJK analyzed and interpreted the data and wrote the manuscript. SL, ESL, HKY, JMH, JSK analyzed and interpreted the data and revised the manuscript. JYC designed and conceptualized the study, interpreted the data, and revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Dr. J. S. Kim serves as an associate editor of Frontiers in Neuro-otology and on the editorial boards of Frontiers in Neuro-ophthalmology, Journal of Neuro-ophthalmology, Journal of Vestibular Research, and Clinical and Translational Neuroscience. The other authors have nothing to disclose.
Ethical approval
This study followed the tenets of the Declaration of Helsinki and was performed according to the guidelines of the Institutional Review Board of Seoul National University Bundang Hospital (B‑2109–707‑001).
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kim, HJ., Lee, SU., Lee, ES. et al. Recurrence and long-term outcomes of Tolosa-Hunt syndrome. J Neurol 271, 935–943 (2024). https://doi.org/10.1007/s00415-023-12044-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-023-12044-y